The Long Run with Luke Timmerman
Timmerman Report
"The Long Run"
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Episodes
Mentioned books
May 9, 2018 • 1h 4min
Ep18: Ethan Perlstein
Ep18: Ethan Perlstein by Timmerman Report
Apr 24, 2018 • 58min
Ep17: Alice Zhang
Ep17: Alice Zhang by Timmerman Report
Mar 13, 2018 • 1h 1min
Ep14: Michael Gilman
Michael Gilman on becoming an entrepreneur.
Feb 28, 2018 • 58min
Ep13: Bruce Booth
Bruce Booth on human capital
Feb 13, 2018 • 59min
Ep12: David Schenkein
Agios CEO David Schenkein on building a cancer R&D engine to last.
Jan 31, 2018 • 1h 6min
Ep11: Stephane Bancel
Stephane Bancel, CEO of Moderna Therapeutics, on his influences.
Jan 16, 2018 • 52min
Ep10: Abbie Celniker
Abbie Celniker of Third Rock Ventures on her career, and chipping away at gender inequities in biotech.
Jan 2, 2018 • 49min
Ep9: Bob More
Bob More on biotech venture capital
Dec 20, 2017 • 1h 2min
Ep8: BioMarin History
Daniel Levine & Dan Maher discuss their book "A Rare Breed."
Dec 5, 2017 • 58min
Ep7: Steve Graham
Steve Graham on racism in Corporate America.


